Published October 29, 2013 | Version v1
Journal article

Primary Tumor Vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact

  • 1. Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital and Medical Faculty, University of Oslo, Oslo (Norway)
  • 2. Department of Obstetrics and Gynecology, The Norwegian Radium Hospital, Oslo University Hospital and Medical Faculty, University of Oslo, Oslo (Norway)

Description

Increased vascularity is a crucial event in the tumor progression and has prognostic significance in various cancers. However, the ultimate role of angiogenesis in the pathogenesis and clinical outcome of vulvar carcinoma patients is still not settled. Tumor vascularity using CD34 stained slides measured by Chalkley counting method as well as hypoxia-inducible factor (HIF)-1α and vascular endothelial growth factor (VEGF) immunoexpression was examined in 158 vulvar squamous cell carcinomas. Associations between vascular Chalkley count, HIF-1α and VEGF expression and clinicopathological factors and clinical outcome were evaluated. High CD34 Chalkley count was found to correlate with larger tumor diameter (P = 0.002), deep invasion (P < 0.001) and HIF-1α (P = 0.04), whereas high VEGF expression correlate significantly with poor tumor differentiation (P = 0.007). No significant association between CD34 Chalkley counts and VEGF expression and disease-specific survival was observed. High HIF-1α expression showed better disease specific survival in both univariate and multivariate analyses (P = 0.001). A significant association between high tumor vascularity and larger tumor size as well as deeper tumor invasion suggests an important role of angiogenesis in the growth and progression of vulvar carcinomas. HIF-1α expression in vulvar carcinomas was a statistically independent prognostic factor

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-13-506; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871003

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
13
Journal Page Range
p. 506
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46123869
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ANGIOGENESIS; CARCINOMAS; GROWTH FACTORS; MULTIVARIATE ANALYSIS
Descriptors DEC
DISEASES; MATHEMATICS; MITOGENS; NEOPLASMS; ORGANIC COMPOUNDS; PROTEINS; STATISTICS

Optional Information

Copyright
Copyright (c) 2013 Dhakal et al.
Notes
PMCID: PMC3871003; PUBLISHER-ID: 1471-2407-13-506; PMID: 24165149; OAI: oai:pubmedcentral.nih.gov:3871003; licensee BioMed Central Ltd.